GovBidAlerts
← My Opportunities
RFPopen🌐 Canada (CanadaBuys)cb-93-39360034

Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.

Department of Health (HC)

Description

Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids. Amendment 1 - Questions & Answers #1 and Amendment to Annex B - SOW Stream 2 Amendment 2 - Questions & Answers #2 and Amendment to Annex A - SOW Stream 1 Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of three categories of emerging drugs: novel synthetic opioids, synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the Office of Legislative and Regulatory Affairs (OLRA) to make more informed regulatory science decisions. For all three streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Novel Opioids, Stimulants, and Synthetic Cannabinoids in three (3) separate streams to Health Canada. Stream 1 - In vitro pharmacological testing of emerging opioids at the Mu Opioid Receptor (MOR). Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream, two (2) streams or all three (3) streams. Up to three (3) contracts may be awarded under this request for proposal.

Documents (10)

  • 📎 annexe-c---edt-flux-3-final.pdf
    application/pdf · 236 KB
    Download
  • 📎 appendix-a---sow-stream-1-amended-20260901.pdf
    Download
    Upstream 403 Forbidden
  • 📎 appendix-a---sow-stream-1-final.pdf
    application/pdf · 376 KB
    Download
  • 📎 appendix-b---sow-stream-2-amendment-1.pdf
    application/pdf · 367 KB
    Download
  • 📎 appendix-b---sow-stream-2-final.pdf
    application/pdf · 306 KB
    Download
  • 📎 appendix-c---sow-stream-3-final.pdf
    Download
    Upstream 403 Forbidden
  • 📎 english-rfp-1000273405-final.pdf
    application/pdf · 840 KB
    Download
  • 📎 qs-as-1.pdf
    application/pdf · 124 KB
    Download
  • 📎 qs-as-2.pdf
    application/pdf · 74 KB
    Download
  • 📎 questions-and-answers-3.pdf
    application/pdf · 53 KB
    Download

Details

Posted
Aug 20, 2026
Response deadline
Sep 25, 2026, 12:00 PM UTC (9d)
Type
RFP
Procurement method
Competitive - Open bidding
Status
Open
Commodity code
*51000000
Trade agreements
*Canada-Colombia Free Trade Agreement *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Canada-Panama Free Trade Agreement *Canada-Peru Free Trade Agreement (CPFTA) *Comprehens
Buyer
Department of Health (HC)
Jurisdiction
Canada (CanadaBuys)
Location
*National Capital Region (NCR)
Reference #
cb-93-39360034
Solicitation #
1000273405
Has Description
true
Amendments
4
Last amended
Sep 15, 2026
Country
Canada
Contact Info Postalcode
K1A0K9
Unspsc Description
*Drugs and Pharmaceutical Products
Notice Type
Request for Proposal
Amendment Number
004
Contact Info City
Ottawa
Selection Criteria
Highest Combined Rating of Technical Merit and Price
Regions Of Opportunity
*Canada
Tender Description
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids. Amendment 1 - Questions & Answers #1 and Amendment to Annex B - SOW Stream 2 Amendm
Contact Info Province
National Capital Region (NCR)
Contact Info Address Line
200 Eglantine Driveway
Contracting Entity Address Postal Code
K1A 0K9
Contracting Entity Address Province
Ontario

Contact

Shallee Doll
shallee.doll@hc-sc.gc.ca
000000000

Similar open opportunities

See opportunities like this one

GovBidAlerts matches this solicitation to similar open bids across 120,000+ open bids from 2,400+ sources. Create a free account to unlock them.

Create free accountno credit card required

This listing is a summary from Canada (CanadaBuys)'s open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.